TrialMolecular metabolism2025

Eloralintide (LY3841136), a novel amylin receptor agonist for the treatment of obesity: From discovery to clinical proof of concept.

Daniel A Briere et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.